ArriVent BioPharma, Inc. ownership breakdown reveals institutions with a 43% stake. Hedge funds own 5.8%, with top 8 shareholders holding over half. Insider ownership is at US$10.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
ArriVent BioPharma, Inc. ownership breakdown reveals institutions with a 43% stake. Hedge funds own 5.8%, with top 8 shareholders holding over half. Insider ownership is at US$10.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.